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To the Editor:
Authors of the recent article on the prevalence of mul-
tiple  sclerosis  (MS)  in  3  US  communities  (1)  presented 
excellent  findings  but  stumbled  on  their  interpretation. 
The article noted that the findings were similar to those 
in a study of MS prevalence from the 1940s and 1950s (2); 
however, the authors did not make a detailed comparison 
with those data. Furthermore, the authors noted that UV 
radiation could explain the findings but did not suggest a 
mechanism for the link.
The data in reference 2 have been analyzed in previous 
studies, which found the distribution of MS in the United 
States to be well described by a quadratic fit to latitude (3). 
This fit is related to wintertime solar UVB (4). Winter is 
the season with the lowest levels of serum 25-hydroxyvita-
min D in humans and the highest rate of viral infections 
(4). In a comparison of the prevalence data from reference 
1 with those from reference 2, the recent data indicate a 
prevalence of approximately 7 cases per 100,000 per year 
less but with the same functional fit (Figure). The qua-
dratic fit to the data in reference 2 explains 75% of the 
variance.
The most likely role of UVB in reducing risk of MS is 
through production of vitamin D. The Epstein-Barr virus 
has strong support as a possible risk factor for MS, as does 
vitamin D in reducing risk (5). Progress is being made in 
understanding the mechanisms by which vitamin D reduc-
es the risk of MS (6). Among its other beneficial proper-
ties, vitamin D strengthens the innate immune system by 
inducing production of cathelicidin and defensins, both of 
which have antimicrobial and antiendotoxin effects (4-6).
Given that the role of vitamin D in reducing the risk of 
MS was first described in 1974 (4), it is disappointing that 
recommendations  to  increase  serum  25-hydroxyvitamin 
D levels, especially in winter, have not been made more 
forcefully  by US, European, and Australian health offi-
cials. The Institute of Medicine of the National Academies 
is scheduled to announce new dietary reference intakes 
for  vitamin  D  and  calcium  in  mid-2010  (www.iom.edu/
Activities/Nutrition/DRIVitDCalcium.aspx), so I hope this 
shortcoming will be rectified soon.
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Figure. Prevalence of multiple sclerosis (MS) by latitude in the United States 
according to data from reference 1 (×) and reference 2 (o). The dashed line 
is a quadratic fit to the data in reference 1, and the solid line is a fit to the 
data in reference 2.VOLUME 7: NO. 4
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